NCT06191289View on ClinicalTrials.gov

Neurocognitive Mechanisms of Perimenstrual Estrogen Effects on Suicidality

PHASE2RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 16, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Suicide
Interventions
DRUG

Transdermal Estradiol

"1mg/24hr transdermal estradiol for 14 days starting day 7 after positive urine luteinizing hormone test~Other Names:~Climara"

OTHER

Placebo

Weekly application of a placebo patch for 14 days starting day 7 after positive urine luteinizing hormone test

Trial Locations (1)

60612

RECRUITING

University of Illinois Neuropsychiatric Institute, Chicago

All Listed Sponsors
lead

University of Illinois at Chicago

OTHER